Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$51.97 - $63.0 $12,368 - $14,994
-238 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$30.8 - $52.47 $7,330 - $12,487
238 New
238 $12,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $946M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Mfa Wealth Advisors, LLC Portfolio

Follow Mfa Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mfa Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mfa Wealth Advisors, LLC with notifications on news.